LUNG Stock Analysis: Buy, Sell, or Hold?
LUNG - Pulmonx Corporation Common Stock
$2.12
0.49 (30.06%)
▲
5d:
+73.77%
30d:
+52.52%
90d:
+57.04%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Get Alerted When LUNG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: LUNG is 32.5% above its trading range ($1.60). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: LUNG is 32.5% above its trading range ($1.60). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: LUNG is currently trading at $2.12, which is considered extended relative to its 30-day fair value range of $1.22 to $1.60.
Technical Outlook: Technically, LUNG is showing sideways momentum. The price is approaching resistance at $2.15. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 30.1% recently.
Market Sentiment: LUNG has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.40 (+60.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LUNG is showing sideways momentum. The price is approaching resistance at $2.15. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 30.1% recently.
Market Sentiment: LUNG has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.40 (+60.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.22 -
$1.60
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price significantly overextended (+32.5% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+30.1%)
- BULLISH: Trading 60.4% below Wall St target ($3.40)
- WARNING: Recommendation downgraded due to 32.5% overvaluation
Trading Range Analysis
30-Day Trading Range
$1.22 -
$1.60
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.17
Resistance Level
$2.15
Current Trend
Sideways
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.25
Wall Street Target
$3.40
(+60.4%)
Revenue Growth (YoY)
-4.6%
Profit Margin
-55.0%
Share & Embed Analysis
Last updated: August 03, 2026 9:38 PM ET
Data refreshes hourly during market hours. Next update: 10:38 PM
Data refreshes hourly during market hours. Next update: 10:38 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LUNG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Geoffrey Beran Rose
SELL
7732 shares
2026-03-02
Glendon E French III
SELL
67813 shares
2026-03-02
Srikanth Radhakrishnan
SELL
10483 shares
2026-03-02
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 51 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 52 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 57 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$236 | 51 HOLD |
